Patent US5958430A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5958430A Expired / Lapsed US ⏱️ 0.0 years remaining

Thin film composition with biological substance and method of making

Assignee: Battelle Memorial Institute Inc
•
Filing: 1998-02-20
•
Granted: 1999-09-28
•
Expires: 2018-02-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides a thin-film composition comprising an underlying substrate of a first material including a plurality of attachment sites; a plurality of functional groups chemically attached to the attachment sites of the underlying substrate; and a thin film of a second material deposited onto the attachment sites of the underlying substrate, and a biologically active substance deposited with the thin-film. Preferably the functional groups are attached to a self assembling monolayer attached to the underlying substrate. Preferred functional groups attached to the underlying substrate are chosen from the group consisting of carboxylates, sulfonates, phosphates, optionally substituted, linear or cyclo, alkyl, alkene, alkyne, aryl, alkylaryl, amine, hydroxyl, thiol, silyl, phosphoryl, cyano, metallocenyl, carbonyl, and polyphosphate. Preferred materials for the underlying substrate are selected from the group consisting of a metal, a metal alloy, a plastic, a polymer, a proteic film, a membrane, a glass or a ceramic. The second material is selected from the group consisting of inorganic crystalline structures, inorganic amorphus structures, organic crystalline structures, and organic amorphus structures. Preferred second materials are phosphates, especially calcium phosphates and most particularly calcium apatite. The biologically active molecule is a protein, peptide, DNA segment, RNA segment, nucleotide, polynucleotide, nucleoside, antibiotic, antimicrobal, radioisotope, chelated radioisotope, chelated metal, metal salt, anti-inflamatory, steriod, nonsteriod anti-inflammatory, analgesic, antihistamine, receptor binding agent, or chemotherapeutic agent, or other biologically active material. Preferably the biologically active molecule is an osteogenic factor the compositions listed above.

Inventors

  • 👤 Allison A. Campbell
  • 👤 Lin Song

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 22:26
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7007

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 66 words
In a thin-film composition comprising an underlying substrate of a first material including a plurality of attachment sites; a plurality of functional groups chemically attached to the attachment sites of the underlying substrate; and a thin film of a second material deposited onto the attachment sites of the underlying substrate, the improvement comprising a biologically active substance incorporated with the thin film of the second material.
Claim 2
Dependent Claim 66 words
In a thin-film composition comprising an underlying substrate of a first material including a plurality of attachment sites; a plurality of functional groups chemically attached to the attachment sites of the underlying substrate; and a thin film of a second material deposited onto the attachment sites of the underlying substrate, the improvement comprising a biologically active substance incorporated with the thin film of the second material.
Claim 3
Dependent Claim 20 words
A composition according to claim 1 wherein a self assembling monolayer containing functional groups are attached to the underlying substrate.
Claim 4
Dependent Claim 45 words
A composition according to claim 1 wherein the functional group attached to the underlying substrate is chosen from the group consisting of carboxylates, sulfonates, phosphates, optionally substituted, linear or cyclo, alkyl, alkene, alkyne, aryl, alkylaryl, amine, hydroxyl, thiol, silyl, phosphoryl, cyano, metallocenyl, carbonyl, and polyphosphate.
Claim 5
Dependent Claim 32 words
A composition according to claim 1 wherein the underlying substrate is selected from the group consisting of a metal, a metal alloy, a polymer, a protein film, a glass or a ceramic.
Claim 6
Dependent Claim 30 words
A composition according to claim 1 wherein the second material is selected from the group consisting of inorganic crystalline structures, inorganic amorphous structures, organic crystalline structures, and organic amorphous structures.
Claim 7
Dependent Claim 13 words
A composition according to claim 5 wherein the second material is a phosphate.
Claim 8
Dependent Claim 14 words
A composition according to claim 5 wherein the second material is a calcium phosphate.
Claim 9
Dependent Claim 23 words
A composition according to claim 5 wherein the second material is selected from the group consisting of octacalcium phosphate, hydroxyapatite and carbonate apatite.
Claim 10
Dependent Claim 43 words
A composition according to claim 1 wherein the biologically active molecule is a protein, peptide, DNA segment, RNA segment, nucleotide, polynucleotide, nucleoside, antibiotic, antimicrobial, radioisotope, chelated radioisotope, chelated metal, metal salt, anti-inflammatory, steroid, nonsteroid anti-inflammatory, analgesic, antihistamine, receptor binding agent, or chemotherapeutic agent.
Claim 11
Dependent Claim 15 words
A composition according to claim 1 wherein the biologically active molecule is an osteogenic factor.
Claim 12
Dependent Claim 71 words
A composition of matter comprising a first porous metal material having a surface and attachment sites located on the surface and a self assembling mono layer containing functional groups provided at attachment sites, and a second crystallite calcium phosphate material nucleated by a functional group at an attachment site and grown as a dense film on the surface of the first material the calcium phosphate having an osteogenic factor incorporated therein.
Claim 13
Dependent Claim 71 words
A composition of matter comprising a first porous metal material having a surface and attachment sites located on the surface and a self assembling mono layer containing functional groups provided at attachment sites, and a second crystallite calcium phosphate material nucleated by a functional group at an attachment site and grown as a dense film on the surface of the first material the calcium phosphate having an osteogenic factor incorporated therein.
Claim 14
Independent Claim 69 words
A method for preparing a multi component coating which comprises treating a first material to produce a plurality of attachment sites on its surface, attaching a plurality of functional groups to the attachment sites, incorporating the functional groups into a thin-film of a second material deposited onto the material and providing a biologically active material which is incorporated onto or into the thin film deposited on the first material.
Claim 15
Independent Claim 69 words
A method for preparing a multi component coating which comprises treating a first material to produce a plurality of attachment sites on its surface, attaching a plurality of functional groups to the attachment sites, incorporating the functional groups into a thin-film of a second material deposited onto the material and providing a biologically active material which is incorporated onto or into the thin film deposited on the first material.
Claim 16
Dependent Claim 22 words
A method according to claim 12 wherein the treating step provides attachment sites to which a self assembling mono-layer can be attached.
Claim 17
Dependent Claim 45 words
A method according to claim 12 wherein the functional group attached to the attachment sites is chosen from the group consisting of carboxylates, sulfonates, phosphates, optionally substituted, linear or cyclo, alkyl, alkene, alkyne, aryl, alkylaryl, amine, hydroxyl, thiol, silyl, phosphoryl, cyano, metallocenyl, carbonyl, and polyphosphate.
Claim 18
Dependent Claim 32 words
A method according to claim 12 wherein the first material is selected from the group consisting of a metal, a metal alloy, a polymer, a protein film, a glass or a ceramic.
Claim 19
Dependent Claim 30 words
A method according to claim 12 wherein the second material is selected from the group consisting of inorganic crystalline structures, inorganic amorphous structures, organic crystalline structures, and organic amorphous structures.
Claim 20
Dependent Claim 13 words
A method according to claim 16 wherein the second material is a phosphate.
Claim 21
Dependent Claim 14 words
A method according to claim 16 wherein the second material is a calcium phosphate.
Claim 22
Dependent Claim 42 words
A method according to claim 16 wherein the biologically active molecule is a protein, peptide, DNA segment, RNA segment, nucleotide, polynucleotide, nucleoside, antibiotic, radioisotope, chelated radioisotope, chelated metal, metal salt, anti-inflamatory, steriod, nonsteriod anti-inflammatory, analgesic, antihistamine, receptor binding agent, or chemotherapeutic agent.
Claim 23
Dependent Claim 15 words
A method according to claim 16 wherein the biologically active molecule is an osteogenic factor.
Claim 24
Dependent Claim 15 words
An implant for use in a mammalian body comprising a composition according to claim 1.
Claim 25
Dependent Claim 35 words
A method for delivery of a biologically active substance which comprises treating an implant according to claim 12 and implanting the implant at a site to which the biologically active substance is to be delivered.
Claim 26
Dependent Claim 11 words
A bone fixation device comprising a composition according to claim 1.
Claim 27
Dependent Claim 17 words
A bone fixation device according to claim 23 wherein the biologically active molecule is an osteogenic factor.
Claim 28
Dependent Claim 14 words
A bone fixation device according to claim 23 wherein the first material is porous.

References Cited (Backward Citations)

US5591453A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-09-27 2003-03-29 2003-09-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-09-27 2007-03-29 2007-09-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-09-27 2011-03-29 2011-09-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag